Please use this identifier to cite or link to this item:
Title: Management of localised renal cell cancer
Authors: Vassallo, Pierre
Keywords: Renal cell carcinoma -- Treatment
Kidneys -- Cancer -- Treatment
Kidneys -- Cancer -- Imaging
Issue Date: 2018
Publisher: Medical Portals Ltd.
Citation: Vassallo, P. (2018). Management of localised renal cell cancer. The Synapse : the Medical Professionals' Network, 17(5), 22-23.
Abstract: Renal cell cancer (RCC) is common, and its incidence is increasing due to increasing exposure to risk factors which include tobacco use, hypertension and obesity. Localised renal cancers are often detected incidentally, and their increased incidence also results from the increased use of imaging. Localised renal cancer now accounts for 60-70% of new RCC cases. Many of these cancers are slow growing and show little tendency to metastasize. Only a minority of patients with localised renal cell cancer have any clinical signs such as haematuria or abdominal pain. These tumours are often detected incidentally on ultrasound but are best characterised using computed tomography (CT), where they may appear as a solid contrast-enhancing mass or a complex cystic lesion. Imaging features are similar on Magnetic Resonance Imaging (MRI) and the latter is equally accurate for the evaluation of renal lesions; it may be used in patients who are allergic to iodinated contrast material, in those with poor renal function, in lesions containing complex haemorrhage or where radiation exposure must be avoided (e.g. pregnancy).
Appears in Collections:The Synapse, Volume 17, Issue 5
The Synapse, Volume 17, Issue 5

Files in This Item:
File Description SizeFormat 
The_Synapse,_17(5)_-_A5.pdf2.25 MBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.